New knee shot for arthritis passes first safety test
NCT ID NCT06704932
First seen Jan 12, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This early-stage study tested a single injection of a new drug (SAR446959) in 32 people aged 45-65 with knee osteoarthritis. The main goal was to check safety and how the drug moves in the body, not to measure pain relief. Participants were monitored for about 6 months after the injection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number : 2760001
Berlin, 14050, Germany
Conditions
Explore the condition pages connected to this study.